These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 10992176

  • 21. Tibolone and transdermal E2/NETA for the treatment of female sexual dysfunction in naturally menopausal women: results of a randomized active-controlled trial.
    Nijland EA, Weijmar Schultz WC, Nathorst-Boös J, Helmond FA, Van Lunsen RH, Palacios S, Norman RJ, Mulder RJ, Davis SR, LISA study investigators.
    J Sex Med; 2008 Mar; 5(3):646-56. PubMed ID: 18304284
    [Abstract] [Full Text] [Related]

  • 22. A comparative study of an estradiol-releasing vaginal ring versus tibolone in postmenopausal women: a transvaginal color Doppler study.
    Botsis D, Kassanos D, Kalogirou D, Antoniou G, Karakitsos P, Zourlas PA.
    Maturitas; 1997 May; 27(1):77-83. PubMed ID: 9158081
    [Abstract] [Full Text] [Related]

  • 23. A double-blind, randomised trial comparing the effects of tibolone and continuous combined hormone replacement therapy in postmenopausal women with menopausal symptoms.
    Hammar M, Christau S, Nathorst-Böös J, Rud T, Garre K.
    Br J Obstet Gynaecol; 1998 Aug; 105(8):904-11. PubMed ID: 9746385
    [Abstract] [Full Text] [Related]

  • 24. Tibolone and low-dose continuous combined hormone treatment: vaginal bleeding pattern, efficacy and tolerability.
    Hammar ML, van de Weijer P, Franke HR, Pornel B, von Mauw EM, Nijland EA, TOTAL Study Investigators Group.
    BJOG; 2007 Dec; 114(12):1522-9. PubMed ID: 17995496
    [Abstract] [Full Text] [Related]

  • 25. A randomized, open-label study of conjugated equine estrogens plus medroxyprogesterone acetate versus tibolone: effects on symptom control, bleeding pattern, lipid profile and tolerability.
    Baracat EC, Barbosa IC, Giordano MG, Haidar MA, Marinho RM, Menegocci JC, Morais KM, Tomaz G, Wehba S.
    Climacteric; 2002 Mar; 5(1):60-9. PubMed ID: 11974560
    [Abstract] [Full Text] [Related]

  • 26. Effects of oral and transdermal hormone replacement therapy on internal carotid artery pulsatility indices in postmenopausal women. A prospective, randomized, comparative study.
    Sendağ F, Terek MC, Karadadaş N, Bilgin O.
    J Reprod Med; 2001 Nov; 46(11):962-8. PubMed ID: 11762152
    [Abstract] [Full Text] [Related]

  • 27. Different effects of tibolone and continuous combined estrogen plus progestogen hormone therapy on sex hormone binding globulin and free testosterone levels--an association with mammographic density.
    Hofling M, Carlström K, Svane G, Azavedo E, Kloosterboer H, Von Schoultz B.
    Gynecol Endocrinol; 2005 Feb; 20(2):110-5. PubMed ID: 15823831
    [Abstract] [Full Text] [Related]

  • 28. Effect of different preparations of hormone therapy on lipid and glucose metabolism, coagulation factors, and bone mineral density in overweight and obese postmenopausal women.
    Osmanağaoğlu MA, Osmanağaoğlu S, Osmanağaoğlu T, Okumuş B, Bozkaya H.
    Fertil Steril; 2005 Aug; 84(2):384-93. PubMed ID: 16084879
    [Abstract] [Full Text] [Related]

  • 29. The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal women.
    Keramaris NC, Christodoulakos GE, Lambrinoudaki IV, Dalamanga A, Alexandrou AP, Bramis J, Bastounis E, Creatsas GC.
    Climacteric; 2007 Oct; 10(5):400-7. PubMed ID: 17852143
    [Abstract] [Full Text] [Related]

  • 30. [Tibolone].
    Jamin C, Poncelet C, Madelenat P.
    Presse Med; 2002 Sep 07; 31(28):1314-22. PubMed ID: 12355994
    [Abstract] [Full Text] [Related]

  • 31. Continuous combined hormone replacement therapy compared with tibolone.
    Al-Azzawi F, Wahab M, Habiba M, Akkad A, Mason T.
    Obstet Gynecol; 1999 Feb 07; 93(2):258-64. PubMed ID: 9932566
    [Abstract] [Full Text] [Related]

  • 32. Evaluation of tibolone effect on arterial resistance in postmenopausal women.
    Grinbaum ML, de S Ferreira JA, Fernandes CE, de Azevedo LH.
    Climacteric; 2003 Jun 07; 6(2):151-8. PubMed ID: 12841886
    [Abstract] [Full Text] [Related]

  • 33. A microarray study on the effect of four hormone therapy regimens on gene transcription in whole blood from healthy postmenopausal women.
    Dahm AE, Eilertsen AL, Goeman J, Olstad OK, Ovstebø R, Kierulf P, Mowinckel MC, Skretting G, Sandset PM.
    Thromb Res; 2012 Jul 07; 130(1):45-51. PubMed ID: 22217510
    [Abstract] [Full Text] [Related]

  • 34. Interleukin-6 and flow-mediated dilatation as markers of increased vascular inflammation in women receiving hormone therapy.
    Vitale C, Cornoldi A, Gebara O, Silvestri A, Wajngarten M, Cerquetani E, Fini M, Ramires JA, Rosano GM.
    Menopause; 2005 Jul 07; 12(5):552-8. PubMed ID: 16145309
    [Abstract] [Full Text] [Related]

  • 35. Contrasting effects of two hormone replacement therapies on the cardiovascular and mammary gland outcomes in surgically postmenopausal monkeys.
    Suparto IH, Williams JK, Cline JM, Anthony MS, Fox JL.
    Am J Obstet Gynecol; 2003 May 07; 188(5):1132-40. PubMed ID: 12748457
    [Abstract] [Full Text] [Related]

  • 36. Randomized, double-masked, 2-year comparison of tibolone with 17beta-estradiol and norethindrone acetate in preventing postmenopausal bone loss.
    Roux C, Pelissier C, Fechtenbaum J, Loiseau-Peres S, Benhamou CL.
    Osteoporos Int; 2002 Mar 07; 13(3):241-8. PubMed ID: 11991445
    [Abstract] [Full Text] [Related]

  • 37. Effects of continuous combined conjugated estrogen/medroxyprogesterone acetate and 17beta-estadiol/norethisterone acetate on lipids and lipoproteins.
    Odmark IS, Bäckström T, Haeger M, Jonsson B, Bixo M.
    Maturitas; 2004 Jun 15; 48(2):137-46. PubMed ID: 15172088
    [Abstract] [Full Text] [Related]

  • 38. Sequentially combined hormone replacement therapy reduces impedance to flow within the uterine and central retinal arteries in healthy postmenopausal women.
    van Baal WM, Kenemans P, Stehouwer CD, Peters-Muller ER, van Vugt JM, van der Mooren MJ.
    Am J Obstet Gynecol; 1999 Dec 15; 181(6):1365-73. PubMed ID: 10601914
    [Abstract] [Full Text] [Related]

  • 39. Differential effect of hormone therapy and tibolone on lipids, lipoproteins, and the atherogenic index of plasma.
    Christodoulakos GE, Lambrinoudaki IV, Economou EV, Papadias C, Panoulis CP, Kouskouni EE, Vlachou SA, Creatsas GC.
    J Cardiovasc Pharmacol; 2006 Apr 15; 47(4):542-8. PubMed ID: 16680067
    [Abstract] [Full Text] [Related]

  • 40. Effect on sexual life--a comparison between tibolone and a continuous estradiol-norethisterone acetate regimen.
    Nathorst-Böös J, Hammar M.
    Maturitas; 1997 Jan 15; 26(1):15-20. PubMed ID: 9032742
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.